新型高剂量化疗方案在复发性/耐药性生殖细胞癌症:我们取得了进展吗?
Christian Kollmannsberger1, Lucia Nappi1, Craig R Nichols2
1BC Cancer Agency, Vancouver, British Columbia, Canada.
概括
用卡博普拉丁和埃托化物治疗复发性生殖细胞瘤的高剂量化疗治疗了大约50%的患者. 一项新的研究测试了一种新的gemcitabine,melphalan,docetaxel和carboplatin组合.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 复发性生殖细胞瘤的标准治疗包括连续的碳烯/乙胺高剂量化疗与干细胞支持.
- 这种已知治疗方法的治愈率约为50%.
研究的目的:
- 评估一种针对复发性生殖细胞瘤的新型组合化疗方案.
- 评估gemcitabine,melphalan,docetaxel和carboplatin在这个患者群体中的疗效和安全性.
主要方法:
- 进行了一项单一中心的第二阶段研究.
- 患有复发性生殖细胞瘤的患者接受了一种新的组合治疗方案.
主要成果:
- 报告了第二阶段研究的结果.
- 这种新的组合包括凝胺,梅尔法兰,多塞塔克塞尔和碳白金.
结论:
- 这种新型组合化疗方案在第二阶段研究中进行了调查.
- 需要进一步分析以确定与标准治疗相比的疗效和安全性.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.7K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
